Aidan's Law
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Apr 10, 2018)
Aidan's Law
This bill authorizes newborn screenings for adrenoleukodystrophy (also known as ALD), which is a hereditary condition that damages the insulating membrane of nerve cells in the brain. The bill authorizes hospitals, child care centers, clinics, and similar institutions to test newborns for ALD in accordance with state protocols; such protocols must be approved by the Discretionary Advisory Committee on Heritable Disorders in Newborns and Children.
The bill also reauthorizes through FY2022 the heritable disorders screening program for newborns and children that is administered by the Health Resources and Services Administration.
What just happenedApr 10, 2018
Referred to the House Committee on Energy and Commerce.
Who’s behind it
- Introduced in HouseApr 10, 2018
- Apr 10, 2018IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Apr 10, 2018IntroReferralIntro-H
Introduced in House
- Apr 10, 2018IntroReferral1000
Introduced in House